Same Indication

Inotuzumab Ozogamicin vs Sitagliptin

Inotuzumab Ozogamicin vs Sitagliptin: Overview

This comparison examines the pharmacological differences between Inotuzumab Ozogamicin and Sitagliptin.

Mechanism of Action

Sitagliptin: DPP-4 inhibitor increasing incretin levels.

Pharmacokinetics

Half-life: Sitagliptin β€” 12.4 hours.

Chemical Properties

Molecular Formula: Sitagliptin β€” C16H15F6N5O.

Molecular Weight: Sitagliptin β€” 407.3140 g/mol.

Type: Inotuzumab Ozogamicin β€” Antibody drug conjugate; Sitagliptin β€” Small molecule.